Results 121–140 of 160 for evusheld in the 'Written Answers'

Written Answers — Department of Health and Social Care: Evusheld (25 May 2022)

Lord Mendelsohn: To ask Her Majesty's Government why they have not recognised the laboratory assay tests conducted in (1) the US, and (2) the EU, on Evusheld against Omicron subvariants.

Written Answers — Department of Health and Social Care: Evusheld (25 May 2022)

Lord Mendelsohn: ...the Written Answer by Parliamentary Under-Secretary of State for the Department of Health and Social Care on 20 April (151279), on what date the UK Health Security Agency began further testing on Evusheld’s effectiveness against the Omicron variant.

Written Answers — Department of Health and Social Care: Evusheld (24 May 2022)

Chris Green: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 March to Question 141960, whether he can provide an estimated date for the availability of Evusheld on the NHS.

Written Answers — Department of Health and Social Care: Evusheld (24 May 2022)

Amy Callaghan: To ask the Secretary of State for Health and Social Care, whether the Government plans to procure the Evusheld drug for treatment of covid-19 for clinically extremely vulnerable people.

Written Answers — Department of Health and Social Care: Evusheld (17 May 2022)

Henry Smith: To ask the Secretary of State for Health and Social Care, with reference to the Answer of 28 April 2022 to Question 141960, what progress has been made on assessing Evusheld for treating immunocompromised patients.

Written Answers — Department of Health and Social Care: Evusheld (17 May 2022)

Rupa Huq: To ask the Secretary of State for Health and Social Care, when his Department plans to approve Evusheld on the NHS to help prevent covid-19 infections in immunocompromised people who cannot be vaccinated.

Written Answers — Department of Health and Social Care: Evusheld (28 Apr 2022)

Henry Smith: To ask the Secretary of State for Health and Social Care, what timeframe the UK Health Security Agency are working to in order to assess the effectiveness of Evusheld against the Omicron variant of covid-19.

Written Answers — Department of Health and Social Care: Coronavirus: Drugs (28 Apr 2022)

Daisy Cooper: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 April 2022 to Question 151279, on Evusheld, how long the Antivirals and Therapeutics Taskforce or its predecessor took to assess and make a recommendation on the available antiviral treatments for covid-19.

Written Answers — Department of Health and Social Care: Coronavirus: Drugs (28 Apr 2022)

Daisy Cooper: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 April 2022 to Question 151279, on Evusheld, whether the UKHSA conducted similar testing against the covid-19 omicron variant for the therapeutic treatments available for that disease.

Written Answers — Department of Health and Social Care: Evusheld (28 Apr 2022)

Daisy Cooper: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 April 2022 to Question 151279, on Evusheld, when the UKHSA began testing Evusheld’s effectiveness against the covid-19 omicron variant; and whether UKHSA has guidance on how long that testing should take.

Written Answers — Department of Health and Social Care: Evusheld (28 Apr 2022)

Daisy Cooper: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 April 2020 to Question 151279, on Evusheld, what other covid-19 variants Evusheld is being tested against.

Written Answers — Department of Health and Social Care: Evusheld (28 Apr 2022)

Daisy Cooper: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 April 2022 to Question 151279, on Evusheld, whether the UKHSA has reviewed studies published by the US Food and Drug Administration and European Medicines Agency on the effectiveness of Evusheld against the covid-19 omicron variant; and for what reason the UKHSA has decided to undertake duplicate studies on...

Written Answers — Department of Health and Social Care: Evusheld: Coronavirus (28 Apr 2022)

Henry Smith: ...for Health and Social Care, what estimate he has made of the number of immunocompromised individuals who have (a) been hospitalised and (b) died as a result of covid-19 since the MHRA authorised Evusheld for use in the UK.

Written Answers — Department of Health and Social Care: Evusheld (28 Apr 2022)

Henry Smith: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 March 2022 to Question 141960 on Evusheld, what progress has been made on the assessment of Evusheld for treating immunocompromised patients.

Written Answers — Department of Health and Social Care: Evusheld (26 Apr 2022)

Caroline Lucas: To ask the Secretary of State for Health and Social Care, what research the Government is commissioning to assess the efficacy of Evusheld against covid-19 variants; when data from that research will be available; and if he will make a statement.

Written Answers — Department of Health and Social Care: Coronavirus: Medical Treatments (26 Apr 2022)

Andrew Gwynne: To ask the Secretary of State for Health and Social Care, if he will commit to making (a) Evusheld and (b) other preventative treatments available via the NHS for prophylactic use for people who are at high risk of severe illness from covid-19 as soon as possible.

Written Answers — Department of Health and Social Care: Evusheld (20 Apr 2022)

Daisy Cooper: To ask the Secretary of State for Health and Social Care, for what reason the Government is conducting tests of the drug, Evusheld, on covid-19 omicron subvariants in the context of the United States Food and Drug Administration and the European Medicines Agency having demonstrated through similar studies that that drug maintains protection.

Written Answers — Department of Health and Social Care: Evusheld (20 Apr 2022)

Daisy Cooper: To ask the Secretary of State for Health and Social Care, whether he plans to place an order for the drug, Evusheld.

Written Answers — Department of Health and Social Care: Evusheld (20 Apr 2022)

Andrew Gwynne: To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the timeframe for Evusheld being available for eligible patients following its recent MHRA approval.

Written Answers — Department of Health and Social Care: Evusheld (20 Apr 2022)

Daisy Cooper: To ask the Secretary of State for Health and Social Care, whether the Government has undertaken an assessment of which immunocompromised patients should be eligible for treatment with the drug, Evusheld, due to their lack of response to the covid-19 vaccine; and whether the Government has plans to undertake antibody testing on those individuals to assess their response.


<< < 1 2 3 4 5 6 7 8 > >>

Create an alert

Advanced search

Find this exact word or phrase

You can also do this from the main search box by putting exact words in quotes: like "cycling" or "hutton report"

By default, we show words related to your search term, like “cycle” and “cycles” in a search for cycling. Putting the word in quotes, like "cycling", will stop this.

Excluding these words

You can also do this from the main search box by putting a minus sign before words you don’t want: like hunting -fox

We also support a bunch of boolean search modifiers, like AND and NEAR, for precise searching.

Date range

to

You can give a start date, an end date, or both to restrict results to a particular date range. A missing end date implies the current date, and a missing start date implies the oldest date we have in the system. Dates can be entered in any format you wish, e.g. 3rd March 2007 or 17/10/1989

Person

Enter a name here to restrict results to contributions only by that person.

Section

Restrict results to a particular parliament or assembly that we cover (e.g. the Scottish Parliament), or a particular type of data within an institution, such as Commons Written Answers.

Column

If you know the actual Hansard column number of the information you are interested in (perhaps you’re looking up a paper reference), you can restrict results to that; you can also use column:123 in the main search box.